GenomeMe

GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since our inception in 2017, our goal has been to develop each of the 260+ clinical IHC antibodies in-house, making us the first and only institution to date to achieve this. We are on track to reach this R&D goal by the end of 2021 - hitting a monumental milestone in the history of our company’s development. Because we develop and manufacture all of our antibodies in-house, we are able to offer our distributors, OEM partners, and valuable end user customers the best value and quality. GenomeMe Lab Inc. is rising to be a dominant player in diagnostic IHC applications, an increasingly essential part of future precision medicine technologies.